Data from Atossa's Phase 2 EVANGELINE Clinical Trial to be Presented at American Association for Cancer Research (AACR) Annual Meeting
Stock Information for Atossa Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.